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Abst ract
Background and purpose: CD4+CD28– lymphocytes can
directly contribute to the instability of atherosclerotic plaque.
This paper attempts to answer the question of the potential
influence of the CD4+CD28– lymphocyte population on the
ultrasound image of atherosclerotic plaque in the common
carotid artery (CCA) wall.
Material and methods: The study involved a group of 109 pa -
tients, aged 45 to 65 years, including 42 patients with first-
ever ischaemic stroke, experiencing symptoms resulting from 
disturbances of the anterior area of cerebral circulation, arter-
ial hypertension and/or type 2 diabetes mellitus (group 1).
Group 2 consisted of 34 patients with mentioned risk factors,
without ischaemic stroke. The control group comprised 33 heal-
thy individuals. The percentage of CD4+CD28– lymphocytes
was assessed with flow cytometry.
Results: A significant difference in the incidence of hetero-
geneous plaques was noted between groups 1 and 3 (p = 
= 0.0023) as well as between group 2 and 3 (p= 0.0005),
whereas groups 1 and 2 did not differ from each other. 
The proportion of CD4+CD28– lymphocytes was similar in
groups 1 and 2 (p= 0.97), but it differed between groups 1
and 3 (p< 0.0001) and between groups 2 and 3 (p< 0.001).
CD4+CD28– lymphocytes and cerebral ischaemic stroke. 
Part II: CD4+CD28– lymphocytes and carotid artery atherosclerotic plaque 
characteristics
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St reszc zenie
Wstêp i cel pracy: Limfocyty CD4+CD28– mog¹ bezpo-
œrednio przyczyniaæ siê do niestabilnoœci blaszek mia¿d¿yco-
wych. Sk³oni³o to autorów pracy do podjêcia badañ nad ewen-
tualnym wp³ywem subpopulacji limfocytów CD4+CD28– na
obraz ultrasonograficzny blaszek mia¿d¿ycowych w œcianie
têtnicy szyjnej wspólnej.
Materia³ i metody: Do badania zakwalifikowano 109 osób
w wieku od 45 do 65 lat, w tym 42 chorych na pierwszy
w ¿yciu udar niedokrwienny mózgu z objawami klinicznymi
wynikaj¹cymi z zaburzeñ przedniego obszaru kr¹¿enia móz -
gowego, nadciœnieniem têtniczym i/lub cukrzyc¹ typu 2 (gru-
pa 1.). Grupê 2. stanowi³o 34 chorych z wymienionymi czyn-
nikami ryzyka, ale bez udaru, a grupê kontroln¹ – 33 osoby
uznane za zdrowe. Odsetek limfocytów CD4+CD28– we
krwi obwodowej analizowano za pomoc¹ cytometrii prze -
p³ywowej.
Wyniki: Wykazano istotn¹ ró¿nicê w czêstoœci wystêpowania
blaszek heterogennych pomiêdzy grupami 1. i 3. (p= 0,0023)
oraz 2. i 3. (p= 0,0005), natomiast grupy 1. i 2. nie ró¿ni³y siê
istotnie pod wzglêdem odsetka osób z tego rodzaju blaszkami.
Odsetek badanych limfocytów CD4+CD28– w grupach 1. i 2.
by³ zbli¿ony (p= 0,97), natomiast istotnie wiêkszy w porów-
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Introduction
About half of all ischaemic cerebral infarctions are
caused by atherosclerotic alterations occurring in extra-
cranial arteries, and less frequently so in large intracra-
nial arteries. According to the currently adopted uni-
form theory of atherosclerosis, it results from complex
interactions between the vascular wall cells, blood cells
and plasma lipoproteins. Consequently, the endothelial
function is disturbed, blood platelets become activated,
and retention, oxidation and aggregation of lipoprote-
ins occur in the vascular wall. Repeated damage to the
endothelium initiates a chronic inflammatory-fibropro-
liferative response of the vascular wall [1-3]. 
It has been proven that in the early phase of athero-
sclerotic alterations CD4+ lymphocytes, which form part
of the inflammatory infiltration in the vessel wall, beco-
me activated. Those cells enhance the inflammatory res -
ponse in the vascular wall [4-7]. Special significance is
attributed to the CD4+ lymphocyte subpopulation, which
is devoid of the CD28 receptor (LcCD4+CD28–). They
are subject to activation despite the lack of stimulation
by B7/CD28 [5,6]. The cells can indirectly contribute
to the instability of atherosclerotic plaque within coro-
nary arteries by creating a microenvironment in the pla-
que which consists of a large number of pro-inflamma-
tory cytokines, especially interferon γ, which is a potential
stimulator of macrophages [8-11]. It appears that
LcCD4+CD28– directly contribute to the destabiliza-
tion and rupture of atherosclerotic plaque in different
pathways. The correlation between the number of
LcCD4+CD28– and the presence of atherosclerotic alte-
rations in the ultrasound examination was analysed in
patients with rheumatoid arthritis, a condition which itself
can be conducive to the growth of the subpopulation of
those lymphocytes, including in the atherosclerotic pla-
que [12]. The involvement of the LcCD4+CD28– sub-
population in the pathogenesis of ischaemic stroke has
so far been discussed in very few papers [13].
Determination of the temporal relation between the
onset of a stroke episode and the accompanying growth
of the subpopulation of those cells in the blood fails 
to resolve a series of problems. One of the most impor-
tant ones is the answer to the following question: does
the increase in the proportion of LcCD4+CD28– in the
blood at the initial stage of acute ischaemic stroke stem
from an immunological-inflammatory response to ner -
vous tissue necrosis, or does it point to the involvement
of those cells in the occurrence of carotid plaques? This
prompted us to undertake studies on the mentioned pro-
blems, with reference to the plaque ultrasound appe-
arance. 
Material and methods
One-hundred and nine persons (56 males and 53 fe -
males), aged 45 to 65 years, were qualified for the stu-
dy and divided into three groups.
Inclusion and exclusion criteria, criteria pertaining
to the diagnosis of the analysed ischaemic stroke risk
factors and details regarding other examinations, includ-
ing the method of determining the expression of the
CD28 receptor on the surface of LcCD4+, have been
presented in part I of the paper [14]. 
A correlation was found between the proportion of
CD4+CD28– lymphocytes in the blood and the number 
of CCA atherosclerotic plaques (Rs = 0.191, p = 0.046).
The proportion of CD4+CD28– lymphocytes in peripheral
blood did not correlate with the ultrasound types of athero-
sclerotic plaques. No correlation between the proportion of
CD4+CD28– lymphocytes and the area of atherosclerotic
plaques was found.
Conclusions: The correlation between the proportion of
CD4+CD28– lymphocytes and the number of atherosclero-
tic plaques within the CCA suggests that the cells are invo-
lved in the mechanism of carotid plaque formation. There is
no proof of the involvement of the above-mentioned cells in
the mechanism of plaque destabilization in those arteries.
Key words: ischaemic stroke, atherosclerotic plaque, common
carotid artery, ultrasonography, CD4+CD28– lymphocytes.
naniu z grup¹ 3. (grupa 1. vs grupa 3.: p< 0,0001; grupa 2.
vs grupa 3.: p< 0,001).
Wnioski: Wspó³wystêpowanie du¿ej liczby limfocytów
CD4+CD28– z du¿¹ liczb¹ heterogennych blaszek mia¿ -
d¿ycowych w têtnicach szyjnych wspólnych nasuwa podej-
rzenie o udzia³ wymienionych komórek w mechanizmie desta-
bilizacji blaszek w tych naczyniach. 
S³owa kluczowe: udar niedokrwienny mózgu, blaszki mia¿ -
d¿ycowe, têtnice szyjne wspólne, ultrasonografia, limfocyty
CD4+CD28–.
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Doppler ultrasound examination of extracranial arte-
ries was performed at the ultrasound laboratory of 
the Neurological Department using the ESAOTE 
AU 5 device equipped with a 7.5 MHz linear probe.
Thickness and echogenicity of the common carotid arte-
ry (CCA) was analysed with the assumption that those
parameters reflect the accumulated influence of all the
atherosclerosis risk factors. The examination covered
both CCAs. The artery was divided into 2 segments in
accordance with the Mannheim Intima-Media Thick-
ness Consensus [15]. The first segment included the
distal 2 cm of the vascular wall of the CCA, adjacent to
the dilatation of the bifurcation. The second segment –
the carotid bifurcation – was included in the carotid dila-
tation up to the flow divider of the internal and external
carotid arteries. The examination was performed in lon-
gitudinal projection, in two planes, anterolateral and
posterolateral and sagittal, so as to evaluate the aspect of
the vessel and its patency. The CCA posterior wall inti-
ma-media thickness (IMT) was measured in B-mode
projection. The location, number and size of athero -
sclerotic plaques were registered.
Atherosclerotic plaques were defined in accordance
with the guidelines of the Mannheim Intima-Media
Thickness Consensus. Atherosclerotic plaque is a focal
structure that encroaches into the arterial lumen by at
least 0.5 mm or 50% of the surrounding IMT value or
demonstrates a thickness > 1.5 mm as measured from
the media-adventitia interface to the intima-lumen inter-
face [15,16]. Atherosclerotic plaques were subjectively
graded by two methods. The first was according to the
relative contribution of echolucent and echogenic pla-
ques using the classification by Gray-Weale et al. [17].
The second method classified the plaques as either homo-
geneous or heterogeneous [18]. The area of the cross-
section of atherosclerotic plaques was determined by
means of the method described by Spence et al. [19-21].
If more than one plaque was visualized in the same arte-
ry, the calculations were aggregated. Systolic and diasto-
lic velocity of blood flow was also evaluated using the
pulsed wave Doppler method so as not to overlook the
presence of hypoechogenic atherosclerotic plaques in 
the examined region. Ultrasound imaging and IMT
measurements were assessed by two persons. Intra-obse-
rver and inter-observer coefficients of variation were
used, according to the Bland-Altman method [22]. Con-
currence for intra-observer and inter-observer variabili-
ty for p-value was p< 0.0001. The data acquired were
archived using the ‘SARO’ ultrasound image archiving
system.
Statistical analysis
Measurable variables demonstrated distributions
significantly different from the normal distribution (Sha-
piro-Wilk test, p< 0.05), which is why non-parametric
tests were employed. In order to demonstrate the signi-
ficance of the differences among more than two groups,
Kruskal-Wallis ANOVA was used, and in order to com-
pare two groups of patients, Mann-Whitney U-test was
used. In order to compare the measurable interrelated
variables (values of parameters measured in the same
patient, e.g. on their right and left side), the Wilcoxon
pair sequence test was used. Correlation strength bet -
ween the variables was evaluated by means of the value
of the Spearman rank correlation coefficient (Rs). Nomi-
nal variables were compared using the χ2 test or Fisher
two-tailed exact test (for 2 × 2 tables). P-value < 0.05
was established as the threshold of statistical significan-
ce. Statistical calculations were performed using the Sta-
tistica 7.1 program.
Results
Atherosclerotic plaques were reported in 20 peo ple
(47.6%) from group 1, in 19 people (55.9%) from 
group 2, and in 6 people from the control group (19.8%).
Type of atherosclerotic plaques Patients with ischaemic Patients with arterial Controls without arterial
stroke (Group 1) hypertension and/or hypertension or diabetes
(n = 42) diabetes mellitus type 2 mellitus type 2
(Group 2) (Group 3)
(n = 34) (n = 33)
Number of hyperechogenic plaques 15 10 3
Number of heterogeneous plaques 28 21 3
Number of hypoechogenic plaques – 3 –
Table 1. Number of atherosclerotic plaques in the studied groups
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The number of consecutive types of atherosclerotic pla-
ques is provided in Table 1. The number of people with
atherosclerotic plaques was similar in groups 1 and 2 
(p= 0.498; Fisher exact test), while it differed between
group 1 and group 3 (p= 0.003) and between group 2
and group 3 (p = 0.003). In groups 1 and 2, athero -
sclerotic plaques occurred significantly more often in
CCA bifurcations than in the CCA (p = 0.0007 and 
p= 0.0006, respectively), while in group 3 no such dif-
ference was found (p= 0.103; Fisher exact test). A signi-
ficant difference in the incidence of heterogeneous pla-
ques was noted between groups 1 and 3 (p= 0.0023) as
well as between groups 2 and 3 (p= 0.0005), whereas
groups 1 and 2 were similar in this regard (p= 0.4875;
Fisher exact test). The proportion of patients with 
hy perechogenic plaques was similar in all three groups
(p = 0.708; χ2 test). No hypoechogenic plaques were
reported for patients from groups 1 and 2, and only for
two patients (5.88%) from group 2 (p= 0.106; χ2 test).
Mean area of atherosclerotic plaques in CCA of
patients with stroke was 18 mm2 (range: 11.8-172 mm2),
in group 2 it was 24 mm2 (range: 11.7-116 mm2), and
in group 3 it was 3 mm2 (12.8-26 mm2). A significant
difference in the area of atherosclerotic plaques was
reported between groups 1 and 3 (p= 0.001) as well as
between groups 2 and 3 (p= 0.0001), while there was
no significant difference between groups 1 and 2 (p= 
= 0.27, Mann-Whitney U-test). 
Figure 1 presents the proportion of LcCD4+CD28–
in the blood of the examined groups. There was no sig-
nificant difference between the proportion of those lym-
phocytes in groups 1 and 2 (p = 0.97). On the other
hand, in both of the groups it was significantly higher
than in group 3 (group 1 vs. group 3: p < 0.0001;
group 2 vs. group 3: p< 0.001).
The proportion of LcCD4+CD28– in the blood cor-
related with the number of CCA atherosclerotic plaques
with no consideration for examined groups (Rs = 
= 0.191, p= 0.046). On the other hand, the propor-
tion of LcCD4+CD28– in peripheral blood did not cor-
relate with the ultrasound types of atherosclerotic
plaques. No correlation between the proportion of
LcCD4+ CD28– lymphocytes and the area of athero-
sclerotic pla ques was found (Table 2).
Discussion
The main structural indicators of atherosclerotic alte-
rations are atherosclerotic plaques. We were primarily
interested in the ultrasound features of the atheroscle-
rotic plaques pointing to their instability (high-risk pla-
ques). It is assumed that in carotid arteries unstable pla-
Fig. 1. Percentage of LcCD4+CD28– in the peripheral blood. Group 1 – pa -
tients with first-ever ischaemic stroke, group 2 – patients with mentioned risk
factors, without ischaemic stroke, group 3 – control group; group 1 vs. 2, 
p = 0.97; group 1 vs. 3, p < 0.0001; group 2 vs. 3, p < 0.001
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group 1 (n = 42) group 2 (n = 34) group 3 (n = 33)
Correlation between proportion Patients with ischaemic Patients with arterial Controls without arterial
of CD4+CD28– and: stroke (Group 1) hypertension and/or hypertension or diabetes
(n = 42) diabetes mellitus type 2 mellitus type 2
(Group 2) (Group 3)
(n = 34) (n = 33)
Rs p-value Rs p-value Rs p-value
Number of plaques 0.053 0.740 –0.007 0.964 –0.013 0.941
Left and right carotid plaques area 0.052 0.743 0.046 0.795 –0.028 0.877
Number of hyperechogenic plaques 0.046 0.772 0.004 0.981 –0.024 0.893
Number of heterogeneous plaques –0.011 0.944 0.059 0.739 0.093 0.605
Number of hypoechogenic plaques – – –0.057 0.747 – –
Table 2. Correlations between the proportion of CD4+CD28– lymphocytes in peripheral blood and the ultrasound parameters of atherosclerotic plaques
Rs – Spearman rank correlation coefficient
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ques, or plaques manifesting an increased risk of rup-
ture, do not contain a large number of lipids and are
more fibrotic [23]. Plaque rupture is caused by an intra-
mural hematoma or dissection. They are heterogeneous
in ultrasound images [24]. 
In our material, heterogeneous plaques predominated
in both group 1 and group 2. This suggests that the main
risk factors for ischaemic stroke – hypertension, type 2 
diabetes, dyslipidaemia, as well as overweight – may con-
tribute to unstable (heterogeneous) plaque formation 
in CCA. More and more significance is also attached to
the inflammatory and immunological mechanisms involved
in the pathogenesis of atherosclerosis and nervous tissue
ischaemia.
Atherosclerotic plaques in the internal carotid artery of
a patient with stroke symptoms demonstrate higher expres-
sion of inflammatory factors than the ones in the arteries of
patients showing no signs of cerebral infarction [25]. 
The most important cells of the immunological sys-
tem taking part in the atherosclerosis-related damage are
monocytes – macrophages and lymphocytes [26-29].
We were especially interested in the LcCD4+CD28–
subpopulation. Those cells can hardly be found in heal-
thy individuals. In persons below 40 years of age they
constitute from 0.1 to 2.5% of LcCD4+ in peripheral
blood [30]. In the group of patients with their first-ever
ischaemic stroke, the proportion of those cells was signi-
ficantly higher than in the control group.
The role played by LcCD4+CD28– in the pathoge-
nesis of cerebral infarction is not yet known [12,31].
Their high proportion in patients included in group 2
suggests that the cells are involved in the development
of atherosclerotic lesions in CCA walls rather than in
the processes reactive to nervous tissue ischaemia.
The question whether the increase in the propor-
tion of LcCD4+CD28– may lead to the destabiliza-
tion of atherosclerotic plaques in the CCA remains open.
We observed a significantly higher proportion of
LcCD4+CD28– in the patients with stroke, arterial
hypertension, diabetes and atherogenic dyslipidaemia,
as well as in the patients burdened with the above risk
factors but with no cerebral infarction episode. Patients
with heterogeneous plaques, considered unstable, pre-
dominated in both groups. However, we observed a cor-
relation between the general number of atherosclerotic
plaques and the proportion of LcCD4+CD28–, but we
did not find a direct correlation between the elevated
proportion of LcCD4+CD28– and the presence of het-
erogeneous plaques in the CCA wall. 
Conclusions
1. The correlation between the proportion of CD4+CD28–
lymphocytes and the number of atherosclerotic pla-
ques within the CCA suggests that the cells are in -
volved in the mechanism of carotid plaque formation. 
2. There is no proof of the involvement of the above-
mentioned cells in the mechanism of plaque destabi-
lization in those arteries.
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